The Aging Workforce Takes Center Stage at the Silver Economy Forum in Helsinki

Philips Ripley Martin joins global leaders to discuss healthy aging through 2030

The first ever Silver Economy Forum, organized by the Global Coalition on Aging (GCOA) and the Finnish Government recently took place in Helsinki, Finland, attended by hundreds of government officials, business leaders, policy-makers and technology innovators worldwide.

During day one of the event, Ripley Martin, General Manager of Aging and Caregiving at Philips, participated in a panel discussion moderated by Dave Ryan, General Manager, Health & Life Sciences Business, at Intel Corporation, which also included thought leaders across health technology including Kalle Killar, Deputy Secretary General of E-services and Innovation Ministry of Social Affairs in Estonia; Mike Devoy, Chief Medical Officer of Bayer and Sara Härmälä, Director, Upgraded – Health Startup Association.

The discussion looked at the scalability of healthcare technology solutions, the significance of partnerships (and pilot programs), and a shift from a ‘diagnosis to prevention’ mindset, with the goal of helping seniors stay out of healthcare settings for longer and live healthier and more fulfilled lives. With connected care and virtual solutions to proactively manage their wellbeing from home, the data from seniors, family caregivers and other care partners informs and better equips care providers to orchestrate appropriate and timely care to manage this growing aging population.

“The impact and implications of an increasingly aging population are no longer limited to a single country or region,” said Martin. “It’s a truly global issue. And while there are certainly local nuances, it was clear from the Silver Economy Forum held in July in Helsinki, Finland, that catering for an aging workforce in particular, is moving up the global business agenda.”

With the inevitability of growing older, the forum challenged leaders to rethink how to manage the aging society, moving beyond the notion that the aging population imposes a burden on society, to recognizing the opportunity for economic growth. Not only does the aging population want to contribute to society – whether it’s working with local communities or becoming caregivers for those less able – they also want to be healthy and active. They want to be included and given a place – and a voice – both in society and in their aging journey.

Once a binary theme, retirement now embodies a mindset shift. Today, many older adults in classical retirement work under new terms, finding ways to give back to the community and fill their time. This cohort is demanding greater flexibility when it comes to their roles, their work hours and the actual time spent in the office, but businesses should be careful not to offer initiatives that focus purely on their age. It’s about shifting mindsets from treating the aging population as “just seniors,” and recognizing the unique individual skills and experience they bring to the workforce. As strong economic drivers, the aging workforce is steepening the labor pool competition, redefining workforce demographics and reimagining the future of work.

The panel session discussion can be viewed in its entirety here.

For more information on the Philips integrated suite of Aging and Caregiving solutions, visit: https://lifeline.philips.com.

Ripley Martin is the General Manager of Aging and Caregiving within Population Health Management at Philips, where he leads Philips’ Lifeline product suite of personal emergency response services and solutions, medication management solutions and health solutions to ease and enrich the aging journey for seniors and their caregivers.

Source: Philips

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.